Your browser doesn't support javascript.
loading
A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China.
Zhou, Shuling; Lv, Hong; Li, Anqi; Li, Ming; Zhong, Siyuan; Lu, Hongfen; Zhou, Xiaoyan; Bai, Qianming; Yang, Wentao.
Afiliação
  • Zhou S; Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, P. R. China.
  • Lv H; Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong'an Road, Shanghai, 200032, P. R. China.
  • Li A; Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, P. R. China.
  • Li M; Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong'an Road, Shanghai, 200032, P. R. China.
  • Zhong S; Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, P. R. China.
  • Lu H; Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong'an Road, Shanghai, 200032, P. R. China.
  • Zhou X; Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, P. R. China.
  • Bai Q; Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong'an Road, Shanghai, 200032, P. R. China.
  • Yang W; Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, P. R. China.
BMC Cancer ; 23(1): 84, 2023 Jan 25.
Article em En | MEDLINE | ID: mdl-36698078

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Guideline Limite: Female / Humans País como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Guideline Limite: Female / Humans País como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article